211 related articles for article (PubMed ID: 9678132)
1. Plasma resistance to activated protein C: an important link between venous thromboembolism and combined oral contraceptives--a short review.
Jespersen J
Eur J Contracept Reprod Health Care; 1996; 1(1):3-11. PubMed ID: 9678132
[TBL] [Abstract][Full Text] [Related]
2. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
3. [Resistance to activated protein C. The most common cause of familial thrombophilia].
Larsen TB; Ravn HB; Lassen JF; Lund ED; Brandslund I
Ugeskr Laeger; 1996 Nov; 158(46):6584-8. PubMed ID: 8966822
[TBL] [Abstract][Full Text] [Related]
4. [The significance of APC resistance (activated protein C) for clinical practice].
Lämmle B; Demarmels Biasiutti F; Wuillemin WA; Stucki B; Furlan M
Praxis (Bern 1994); 1997 Jan; 86(5):154-61. PubMed ID: 9064734
[TBL] [Abstract][Full Text] [Related]
5. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
6. Resistance to activated protein C: a major cause of inherited thrombophilia.
Jensen R; Ens GE
Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
[TBL] [Abstract][Full Text] [Related]
7. Coagulation factor V and thrombophilia: background and mechanisms.
Segers K; Dahlbäck B; Nicolaes GA
Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
[TBL] [Abstract][Full Text] [Related]
8. Life threatening pulmonary embolus in a factor V Leiden carrier on oral contraceptives: a case report.
Saif MW; Volpe BT; Dailey M; Tsongalis GJ
Conn Med; 1997 Jun; 61(6):333-7. PubMed ID: 9238827
[TBL] [Abstract][Full Text] [Related]
9. Ischemic colitis and acquired resistance to activated protein C in a woman using oral contraceptives.
Mann DE; Kessel ER; Mullins DL; Lottenberg R
Am J Gastroenterol; 1998 Oct; 93(10):1960-2. PubMed ID: 9772065
[TBL] [Abstract][Full Text] [Related]
10. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
[TBL] [Abstract][Full Text] [Related]
11. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C.
Luddington R; Jackson A; Pannerselvam S; Brown K; Baglin T
Thromb Haemost; 2000 Feb; 83(2):204-8. PubMed ID: 10739373
[TBL] [Abstract][Full Text] [Related]
12. Resistance to activated protein C and a novel factor V gene mutation.
Voelkerding KV
Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of thrombophilia based on coagulation and genetic studies].
Bałszan-Kowalska I
Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
[TBL] [Abstract][Full Text] [Related]
14. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
Price DT; Ridker PM
Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
[TBL] [Abstract][Full Text] [Related]
15. [Factor V Leiden and activated protein C resistance].
Cauchie P; Hilbert P
Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
[TBL] [Abstract][Full Text] [Related]
16. [Changes in hemostasis system in patients with hereditary thrombophilia caused by mutation of blood coagulation factor V ( factor V Leiden)].
Papaian LP; Kobilianskaia VA; Sheĭdina AM; Baranovskaia SS; Sirotkina OV; Kargin VD; Saltykova NB; Beliazo OE; Golovina OG; Papaian KA; Tarkovskaia LR
Ter Arkh; 2001; 73(7):47-51. PubMed ID: 11523408
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
[TBL] [Abstract][Full Text] [Related]
18. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
19. The emotional impact of genetic testing and aspects of counseling prior to prescription of oral contraceptives.
Gartner V; Weber M; Eichinger S
Contraception; 2008 Nov; 78(5):392-8. PubMed ID: 18929736
[TBL] [Abstract][Full Text] [Related]
20. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
